Despite Nox2 being expressed in multiple cell types that are potentially involved in Ang II–dependent pathology, we find that targeted inhibition of Nox2 in Tregs is sufficient to significantly ameliorate Ang II–induced hypertension and heart remodeling. This evidence concerns the gene CYBB and Hypertension.